[PL-01] Plenary Lecture 01

[PL-01-1] Mechanistic Insights and Therapeutic Approaches to Restore Muscle Function in Muscular Dystrophy

Kevin Campbell^1,2 (1.University of Iowa, USA, 2.Howard Hughes Medical Institute, USA)

Kevin P. Campbell, Ph.D. is an investigator with the Howard Hughes Medical Institute, Director of the Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, and Chair, Department of Molecular Physiology and Biophysics at the Carver College of Medicine, University of Iowa.

Campbell received a Ph.D. in biophysics from the University of Rochester in 1979. He completed his post-doctoral training at the University of Toronto and joined the University of Iowa College of Medicine as an Assistant Professor in Physiology and Biophysics in 1981.

Campbell is internationally recognized for his fundamental contributions to glycobiology and muscular dystrophy research. His early studies at the University of Iowa involved elucidating the structure and function of calcium channels in skeletal muscle. For the past twenty years, Campbell and his colleagues have actively investigated the molecular pathogenesis of glycosylation-deficient muscular dystrophy. His laboratory has used biochemical, cell biological, genetic, and physiological techniques to identify and define disease mechanisms that cause various forms of this disease.

Campbell was elected to the Institute of Medicine, the National Academy of Sciences, and the American Academy of Arts and Sciences. Campbell was the recipient of the American Society for Biochemistry and Molecular Biology 2020 Herbert Tabor Research Award.